Risk factors for 30-day mortality after resection of lung cancer and prediction of their magnitude
- PMID: 17573442
- PMCID: PMC2117132
- DOI: 10.1136/thx.2007.079145
Risk factors for 30-day mortality after resection of lung cancer and prediction of their magnitude
Abstract
Background: There is considerable variability in reported postoperative mortality and risk factors for mortality after surgery for lung cancer. Population-based data provide unbiased estimates and may aid in treatment selection.
Methods: All patients diagnosed with lung cancer in Norway from 1993 to the end of 2005 were reported to the Cancer Registry of Norway (n = 26 665). A total of 4395 patients underwent surgical resection and were included in the analysis. Data on demographics, tumour characteristics and treatment were registered. A subset of 1844 patients was scored according to the Charlson co-morbidity index. Potential factors influencing 30-day mortality were analysed by logistic regression.
Results: The overall postoperative mortality rate was 4.4% within 30 days with a declining trend in the period. Male sex (OR 1.76), older age (OR 3.38 for age band 70-79 years), right-sided tumours (OR 1.73) and extensive procedures (OR 4.54 for pneumonectomy) were identified as risk factors for postoperative mortality in multivariate analysis. Postoperative mortality at high-volume hospitals (> or = 20 procedures/year) was lower (OR 0.76, p = 0.076). Adjusted ORs for postoperative mortality at individual hospitals ranged from 0.32 to 2.28. The Charlson co-morbidity index was identified as an independent risk factor for postoperative mortality (p = 0.017). A prediction model for postoperative mortality is presented.
Conclusions: Even though improvements in postoperative mortality have been observed in recent years, these findings indicate a further potential to optimise the surgical treatment of lung cancer. Hospital treatment results varied but a significant volume effect was not observed. Prognostic models may identify patients requiring intensive postoperative care.
Conflict of interest statement
Competing interests: None.
Comment in
-
Risk and benefit: the eternal Yin and Yang of thoracic surgery.Thorax. 2007 Nov;62(11):929-30. doi: 10.1136/thx.2007.082982. Thorax. 2007. PMID: 17965075 Free PMC article.
Similar articles
-
Aspects of survival from colorectal cancer in Denmark.Dan Med J. 2012 Apr;59(4):B4428. Dan Med J. 2012. PMID: 22459726
-
Surgical treatment of lung cancer: predicting postoperative morbidity in the elderly population.J Thorac Cardiovasc Surg. 2012 Jun;143(6):1314-23. doi: 10.1016/j.jtcvs.2011.09.072. Epub 2012 Feb 15. J Thorac Cardiovasc Surg. 2012. PMID: 22341420
-
Lung cancer surgery: the first 60 days. A population-based study.Eur J Cardiothorac Surg. 2006 May;29(5):824-8. doi: 10.1016/j.ejcts.2006.01.055. Epub 2006 Mar 7. Eur J Cardiothorac Surg. 2006. PMID: 16520052
-
Postoperative mortality in lung cancer patients.Ann Thorac Cardiovasc Surg. 2007 Dec;13(6):373-7. Ann Thorac Cardiovasc Surg. 2007. PMID: 18292718 Review.
-
In elderly patients with lung cancer is resection justified in terms of morbidity, mortality and residual quality of life?Interact Cardiovasc Thorac Surg. 2010 Jun;10(6):1015-21. doi: 10.1510/icvts.2010.233189. Epub 2010 Mar 30. Interact Cardiovasc Thorac Surg. 2010. PMID: 20354037 Review.
Cited by
-
Postoperative mortality in New Zealand following general anaesthetic: demographic patterns and temporal trends.BMJ Open. 2020 Sep 24;10(9):e036451. doi: 10.1136/bmjopen-2019-036451. BMJ Open. 2020. PMID: 32973053 Free PMC article.
-
Improving lung cancer outcomes by improving the quality of surgical care.Transl Lung Cancer Res. 2015 Aug;4(4):424-31. doi: 10.3978/j.issn.2218-6751.2015.08.01. Transl Lung Cancer Res. 2015. PMID: 26380183 Free PMC article.
-
Risk and benefit: the eternal Yin and Yang of thoracic surgery.Thorax. 2007 Nov;62(11):929-30. doi: 10.1136/thx.2007.082982. Thorax. 2007. PMID: 17965075 Free PMC article.
-
Effectiveness of pulmonary rehabilitation and correlations in between functional parameters, extent of thoracic surgery and severity of post-operative complications: randomized clinical trial.J Thorac Dis. 2018 Jun;10(6):3519-3531. doi: 10.21037/jtd.2018.05.202. J Thorac Dis. 2018. PMID: 30069349 Free PMC article.
-
Efficacy of a smartphone application assisting home-based rehabilitation and symptom management for patients with lung cancer undergoing video-assisted thoracoscopic lobectomy: a prospective, single-blinded, randomised control trial (POPPER study).Int J Surg. 2025 Jan 1;111(1):597-608. doi: 10.1097/JS9.0000000000001845. Int J Surg. 2025. PMID: 38905505 Free PMC article. Clinical Trial.
References
-
- Cancer Registry of Norway Cancer in Norway 2005. 2006. http://www.kreftregisteret.no/forekomst_og_overlevelse_2005/cin2005.pdf
MeSH terms
LinkOut - more resources
Full Text Sources
Medical